Colon
Half of patients flared within two years of stopping anti-TNF for UC, trial finds

  • September 15

Liver
Baveno VIII shifts portal hypertension care toward prevention

  • September 14

Colon
AI's deskilling question has a GI metric: ADR

  • September 11

Liver
Surgery after systemic therapy delays treatment failure in advanced liver cancer, phase 3 trial finds

  • September 10

The AGA Research Foundation helps advance discoveries

  • September 15

With federal research funding increasingly uncertain, AGA member support helped fund 84 investigators this year and sustain research that could shape the future of digestive health care.

BROWSE BY TOPICS

The New Gastroenterologist

Substance use disorders in gastroenterology and hepatology: A practical guide for the general gastroenterologist

  • August 3

  • by Isabelle S. Byers, MD, Michelle Russin, MD, Sasha Deutsch-Link, MD, MSCR

GI and liver complications often bring these patients in first, and the authors say gastroenterologists are well placed to screen and treat.

Esophagus
Bridging the rural divide: Building a motility center in a critical access hospital

  • August 3

  • by Amber Charoen, MD, W. Michael McDonnell, MD, AGAF

“If large urban centers can run comprehensive motility labs, why can't a critical access hospital?”

Is professional coaching worth it? A practical guide for early-career gastroenterologists

  • August 3

  • by Mariam Naveed, MD, FACG, Kathryn E. Hutchins, MD, FACG

Two program directors on why coaching belongs at the start of a GI career, not after something has already gone wrong.

The Latest

September 15
Colon
Half of patients flared within two years of stopping anti-TNF for UC, trial finds

  • by Olivia Anderson

In BIOSTOP, 80% of patients who stopped anti-TNF were in endoscopic remission at two years vs. 96% who continued — short of the trial’s noninferiority margin.

September 15
The AGA Research Foundation helps advance discoveries

  • by AGA

With federal research funding increasingly uncertain, AGA member support helped fund 84 investigators this year and sustain research that could shape the future of digestive health care.

September 14
Liver
Baveno VIII shifts portal hypertension care toward prevention

  • by Doug Brunk

“Portal hypertension management is becoming increasingly preventive, personalized, and noninvasive.”

September 11
Colon
AI's deskilling question has a GI metric: ADR

  • by Julia Cipriano

As medicine debates whether AI could erode clinical skills, one multicenter study found unassisted ADR fell 6 percentage points after CADe was introduced.

September 10
Liver
Surgery after systemic therapy delays treatment failure in advanced liver cancer, phase 3 trial finds

  • by Doug Brunk

“Continuing systemic therapy should no longer be the default option for patients who respond favorably.”